Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Medicenna Therapeutics Corp. (MDNAF) had Return on Investments of -61.82% for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-8.48M |
|
-- |
|
-- |
|
$14.67M |
|
$-14.67M |
|
$6.18M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
$-14.67M |
|
$-14.63M |
|
76.67M |
|
76.67M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$20.25M |
|
$0.01M |
|
$0.15M |
|
$20.40M |
|
$3.19M |
|
-- |
|
$3.49M |
|
$6.67M |
|
$13.72M |
|
$13.69M |
|
$13.72M |
|
78.22M |
|
| Cash Flow Statement Financials | |
$-11.85M |
|
$-0.02M |
|
$16.88M |
|
$12.21M |
|
$17.85M |
|
$5.65M |
|
$1.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-61.82% |
|
-61.99% |
|
-41.59% |
|
|
Return on Investments |
-61.82% |
$0.18 |
|
$-0.15 |
|
$-0.15 |
|